Inari Medical Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Inari Medical, Inc. (NARI) Tops Q2 EPS by 2c, Revenues Beat
August 11, 2020 4:25 PM EDTInari Medical, Inc. (NASDAQ: NARI) reported Q2 EPS of ($0.16), $0.02 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $25.4 million versus the consensus estimate of $13.15 million.
Second Quarter Highlights:
Treated more patients in the second quarter of 2020 than in the first quarter of 2020, despite COVID-19... More


